Back to mobile site

More on ALLR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-31.6% Growth)
- Ratings (5.0 Score)

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Allarity Therapeutics (NQ:ALLR)
Delayed: 0.87 +0.02 (2.35%)
Prev. Close $0.85  
Open$0.84 
52 Wk High$ 
52 Wk Low$ 
Day High$0.90 
Day Low$0.84 
P/E N/A  
EPS$ 
Volume71,070 


Oct 9, 2026 05:13 PM Form 4 Allarity Therapeutics, For: Jan 22 Filed by: Graff Jeremy R.
Oct 1, 2026 08:00 AM Form 8-K Allarity Therapeutics, For: Sep 30
Sep 30, 2026 09:00 AM Allarity updates DRP technology with new patents and lab certification
Sep 30, 2026 09:00 AM Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
Sep 29, 2026 08:01 AM Form 8-K Allarity Therapeutics, For: Sep 28
Sep 28, 2026 08:01 AM Allarity adds proteomics and cell line research to its laboratory
Sep 28, 2026 08:00 AM Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
Sep 28, 2026 08:00 AM Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
Sep 16, 2026 08:00 AM Form 8-K Allarity Therapeutics, For: Sep 15
Sep 15, 2026 08:03 AM Allarity wins Japanese patent for stenoparib diagnostic tool
View All Articles

Entities mentioned with ALLR

View All Entities